Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 1057-1063

  Khoo, S K ^a   Pendek, R ^b   Nickolov, R ^c   Luccio Camelo, D C ^d,e   Newton, T L ^a   Massie, A ^a   Petillo, D ^a   Menon, J ^f   Cameron, D ^g   Teh, B T ^a,h   Chan, S P ^b  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^c FAYETTEVILLE STATE UNIVERSITY   (United States)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f Queen Elizabeth Hospital   (Malaysia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

^h DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR INTERACTING PROTEIN; ONCOPROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ABORIGINE; ACROMEGALY; ARTICLE; BORNEO; CHROMOSOME 21Q; CHROMOSOME 3Q; CHROMOSOME 8Q; CLINICAL ARTICLE; DNA FLANKING REGION; EXON; FAMILIAL CANCER; FAMILY STUDY; FEMALE; FRAMESHIFT MUTATION; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC SCREENING; GROWTH HORMONE SECRETING ADENOMA; HUMAN; LINKAGE ANALYSIS; MALE; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; PENETRANCE; PHENOTYPE;

ACROMEGALY; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FAMILY; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMAN GROWTH HORMONE; HUMANS; LOD SCORE; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; YOUNG ADULT;

EID: 72749104668     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0287     Document Type: Article

References (24)

1. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T et al. 2007 Mutations in the aryl hydrocarbon receptor-interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 92 1952-1955. (Pubitemid 46997216)
2. Beckers A & Daly AF 2007 The clinical, pathological, and genetic features of familial isolated pituitary adenomas. European Journal of Endocrinology 157 371-382. (Pubitemid 350018439)
3. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthen L, Saller B et al. 2003 Serum insulin-like growth factor I reference values for an automated chemi-luminescence immunoassay system: results from a multicenter study. Hormone Research 60 53-60.
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
5. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T et al. 2006a Clinical characterization of familial isolated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 91 3316-3323. (Pubitemid 44402097)
6. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A 2006b High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism 91 4769-4775. (Pubitemid 44917305)
7. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez- Roqueplo AP, Tamburrano G et al. 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 92 1891-1896. (Pubitemid 46997206)
8. Donangelo I, Araujo PB, Antenuzi D, Farage M, Marcondes J, Filho PN & Gadelha MR 2005 Tumor deletion mapping of chromosomal region 13q14 in 43 growth hormone secreting pituitary adenomas. Endocrine 28 131-136. (Pubitemid 43037671)
9. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD & Frohman LA 2000 Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. Journal of Clinical Endocrinology and Metabolism 85 707-714. (Pubitemid 32273658)
10. Genin E, Feingold J & Clerget-Darpoux F 2008 Identifying modifier genes of mongenic disease: strategies and difficulties. Human Genetics 124 357-368.
11. Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T & Yoshimoto K 2007 The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GHsecreting adenomas. Clinical Endocrinology 66 499-502. (Pubitemid 46434927)
12. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics 26 89-92. (Pubitemid 30692864)
13. Kong A & Cox NJ 1997 Allele-sharing models: LOD scores and accurate linkage tests. American Journal of Human Genetics 61 1179-1188. (Pubitemid 27492328)
14. Kruglyak L & Lander ES 1998 Faster multipoint linkage analysis using Fourier transforms. Journal of Computational Biology 5 1-7. (Pubitemid 28153001)
15. Kruglyak L, Daly MJ, Reeve-Daly MP & Lander ES 1996 Parametric and nonparametric linkage analysis: a unified multipoint approach. American Journal of Human Genetics 58 1347-1363. (Pubitemid 26153846)
16. Lander E & Kruglyak L 1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genetics 11 241-247.
17. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J et al. 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familal and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 93 2390-2401. (Pubitemid 351831563)
18. Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhaes AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO et al. 2007 Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology 157 383-391. (Pubitemid 350018440)
19. O'Connell JR & Weeks DE 1998 PedCheck: a program for identification of genotype incompatibilities in linkage analysis. American Journal of Human Genetics 63 259-266.
20. RaitilaA, Georgitsi M, Karhu A, Tuppurainen K, Makinen MJ, Birkenkamp-Demtroder K, Salmenkivi K, Orntoft TF, Arola J, Launonen V et al. 2007 No evidence of somatic aryl hydrocarbon receptor-interacting protein mutations in sporadic endocrine neoplasia. Endocrine-Related Cancer 14 901-906. (Pubitemid 350074077)
21. Schneider HJ, Sievers C, Saller B, Wittchen HU & Stalla GK 2008 High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clinical Endocrinology 69 432-435.
22. Soares BS & Frohman LA 2004 Isolated familial somatotropinoma. Pituitary 7 95-101.
23. Toledo RA, Lourenco DM Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP & Dahia PL 2007 Germline mutation in the aryl hydrocarbon receptor-interacting protein gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism 92 1934-1937. (Pubitemid 46997212)
24. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230. (Pubitemid 43801151)